New Zealanders will be part of a world-first clinical trial into how to treat a dangerous condition that causes heart attacks in young women – including new mothers.
There has been a lack of research into heart conditions that affect women specifically, and the work is part of a big push to change that.
Spontaneous coronary artery dissection (SCAD) occurs when a tear forms in the artery. It was the cause of a third of heart attacks in women under 50 and half of all heart attacks in pregnancy.
The condition was often missed when patients turned up to hospital with chest pain because otherwise-healthy, young women were not considered high risk for heart attacks.
The Heart Foundation was helping to fund the research. Clinical director Gerry Devlin said he hoped it would lead to better, potentially life-saving, understanding.
“It’s a really important trial. It will help define guidelines around the world about how we manage people presenting with this,” he said.
SCAD was different to other heart attacks.
“What happens is rather than the silting up that occurs in arteries over many years that can cause a blockage, with SCAD you get a tear in the wall of the artery and that tear can extend and lead to a blockage in the heart itself and cause a heart attack.”
Heart attack patients were commonly treated with blood thinners — sometimes aspirin, sometimes aspirin plus another drug.
But it was unclear which was the best option for people with SCAD because blood thinners could potentially exacerbate the effects of the tear, Devlin said.
The work would look at whether to try one blood thinner or two and whether the timing of the medication made a difference.
50 New Zealanders would take part in the global trial of 3250 people.
They would be selected after turning up at hospital with the condition.
Devlin said New Zealand was part of a network of heart funders and researcher around the world working together.
“What we are trying to do is create an environment where we can get clinical trials answering important questions done much more quickly by the power of doing it in many countries,” he said.
Many previous heart attack studies had tended to focus more on middle-aged men but there was now understanding that what worked for them, may not work for women.
Devlin said he had never treated a man with SCAD.
The condition was being identified more now because of improvements in diagnostic imaging and it was likely it would be more prevalent than first realised as that technology improves and expands, he said.
The trial was one of 31 research projects given grants totalling $4.2 million announced by the Heart Foundation today.
The foundation had given away $99m for research since it first began in 1968.
rnz.co.nz
The morning’s headlines in 90 seconds, including Christopher Luxon defending the decision not to recognise Palestine, a Silver Ferns star has spoken out about the team’s coaching drama, and 2025’s Bird of the Year is named. (Source: 1News)
